Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update

Parkinson’s disease (PD) has long been seen as a disorder caused by degeneration of the dopaminergic system, leading to the classic motor manifestations of the disease. However, there is now overwhelming evidence that PD is more than a disease merely caused by dopamine depletion. It is well-known th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS chemical neuroscience 2017-05, Vol.8 (5), p.973-986
Hauptverfasser:	Huot, Philippe, Sgambato-Faure, Véronique, Fox, Susan H, McCreary, Andrew C
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antiparkinson Agents - pharmacology Antiparkinson Agents - therapeutic use Cognitive science Disease Models, Animal Humans Life Sciences Motor Activity - drug effects Parkinson Disease - drug therapy Parkinson Disease - metabolism Serotonin - metabolism Serotonin Agents - pharmacology Serotonin Agents - therapeutic use Translational Medical Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!